Bottom line
What does EIHSX hold?
EIHSX held 42 positions as of May 31, 2026. Its largest holding is Eli Lilly & Co at 12.47% of the fund, and the top 10 positions add up to 58.6%. By asset type it is 99% stocks, 0% cash & short-term funds.
Updated Jul 27, 2026
EIHSX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | Stocks | 12.47% | $94.5M |
| 2 | AbbVie Inc | Stocks | 6.46% | $48.9M |
| 3 | Johnson & Johnson | Stocks | 6.45% | $48.9M |
| 4 | AstraZeneca PLC | Stocks | 6.24% | $47.3M |
| 5 | UnitedHealth Group Inc | Stocks | 5.49% | $41.6M |
| 6 | Roche Holding AG | Stocks | 5.44% | $41.2M |
| 7 | Merck & Co Inc | Stocks | 5.08% | $38.5M |
| 8 | Bristol-Myers Squibb Co | Stocks | 4.25% | $32.2M |
| 9 | Vertex Pharmaceuticals Inc | Stocks | 3.38% | $25.6M |
| 10 | Gilead Sciences Inc | Stocks | 3.34% | $25.3M |
| 11 | Sanofi SA | Stocks | 2.95% | $22.3M |
| 12 | Thermo Fisher Scientific Inc | Stocks | 2.79% | $21.2M |
| 13 | Intuitive Surgical Inc | Stocks | 2.72% | $20.6M |
| 14 | Stryker Corp | Stocks | 2.21% | $16.8M |
| 15 | Boston Scientific Corp | Stocks | 2.18% | $16.5M |
| 16 | Medtronic PLC | Stocks | 1.80% | $13.7M |
| 17 | Lonza Group AG | Stocks | 1.77% | $13.4M |
| 18 | Novo Nordisk A/S | Stocks | 1.71% | $13.0M |
| 19 | Abbott Laboratories | Stocks | 1.65% | $12.5M |
| 20 | Novartis AG | Stocks | 1.65% | $12.5M |
| 21 | Argenx SE | Stocks | 1.61% | $12.2M |
| 22 | Royalty Pharma PLC | Stocks | 1.58% | $12.0M |
| 23 | Neurocrine Biosciences Inc | Stocks | 1.41% | $10.7M |
| 24 | Mettler-Toledo International Inc | Stocks | 1.36% | $10.3M |
| 25 | Straumann Holding AG | Stocks | 1.34% | $10.1M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 27, 2026